What are the most common side effects of Rybelsus?

The label lists nausea, abdominal pain, diarrhoea, decreased appetite, vomiting, constipation among reactions reported in at least 5% of patients. A frequency table with exact percentages is in the label itself, linked below — we do not restate percentages second-hand.

Do the side effects mean the price is not the issue?

They are the same issue. The reactions above are worst during titration, and titration is exactly when providers charge an introductory rate — so the months you are most likely to stop are the months priced to look cheap. What the maintenance dose costs is on the card.

← Rybelsus (oral semaglutide, diabetes label)

Rybelsus (oral semaglutide, diabetes label) side effects

Taken from the FDA label, in the label's own order: what is common, what is serious, and who cannot take it at all. No percentages are repeated second-hand and nothing here is a recommendation.

No clinician has reviewed this page. Every clinical statement on it is drawn from the FDA label or the trial cited beside it, and every price carries the date it was verified — but that is sourcing, not medical review, and the two are not the same thing. What we do and do not check · Who checked the price

Last updated 2026-01-30 — the version of the FDA label this page quotes. Read and dated by Alex Seot.

What are the side effects of Rybelsus?

The FDA label for Rybelsus lists nausea, abdominal pain, diarrhoea, decreased appetite, vomiting among the reactions reported in at least 5% of patients. It carries a boxed warning, the strongest the FDA issues: In rodents this molecule caused thyroid C-cell tumours. The serious reactions the label names separately are Acute pancreatitis, Diabetic retinopathy complications, Acute kidney injury from dehydration, Gallbladder disease among others — rarer than the common list and the reason the label exists in the form it does. It is contraindicated in A personal or family history of medullary thyroid carcinoma, or MEN 2, A prior serious hypersensitivity reaction to semaglutide or any excipient, meaning the label says not to prescribe it in those cases at all rather than to weigh it up. Every line above is quoted from FDA prescribing information for RYBELSUS and OZEMPIC tablets rather than summarised from a secondary source, because a side-effect list paraphrased twice stops being the label.

Boxed warning — the strongest warning the FDA issues

In rodents this molecule caused thyroid C-cell tumours. Whether it does so in people is unknown, and the label carries that as a boxed warning. It is contraindicated outright with a personal or family history of medullary thyroid carcinoma or MEN 2.

Common, and usually manageable

Reactions the label reports in at least 5% of patients.

nausea
abdominal pain
diarrhoea
decreased appetite
vomiting
constipation

One label now covers Rybelsus and the oral form of Ozempic. Approved for type 2 diabetes rather than for weight.

Serious, and worth knowing before you start

Acute pancreatitis
Diabetic retinopathy complications
Acute kidney injury from dehydration
Gallbladder disease
Hypoglycaemia when used with insulin or an insulin secretagogue
Pulmonary aspiration under general anaesthesia

Who cannot take it

A personal or family history of medullary thyroid carcinoma, or MEN 2
A prior serious hypersensitivity reaction to semaglutide or any excipient

Each of these, on its own

What the label says, why it happens, how it tracks the dose schedule and the point at which it stops being ordinary.

What it costs

Everything on Rybelsus

Questions

What are the most common side effects of Rybelsus?: The label lists nausea, abdominal pain, diarrhoea, decreased appetite, vomiting, constipation among reactions reported in at least 5% of patients. A frequency table with exact percentages is in the label itself, linked below — we do not restate percentages second-hand.
Who should not take it?: The label contraindicates it in these cases: A personal or family history of medullary thyroid carcinoma, or MEN 2; A prior serious hypersensitivity reaction to semaglutide or any excipient.
Do the side effects mean the price is not the issue?: They are the same issue. The reactions above are worst during titration, and titration is exactly when providers charge an introductory rate — so the months you are most likely to stop are the months priced to look cheap. What the maintenance dose costs is on the card.

Source: FDA prescribing information for RYBELSUS and OZEMPIC tablets, the version published 2026-01-30. Information only, not medical advice: a side effect you are having is a conversation with your prescriber, not with a comparison site.